Long‐term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.4068
Abstract: We examined the characteristics of breast cancer patients with oligometastases (OM) treated with stereotactic ablative body radiotherapy (SABR) to identify factors associated with local progression, distant metastasis progression, time to subsequent therapy, progression‐free survival (PFS),… read more here.
Keywords: ablative body; body radiotherapy; breast cancer; cancer ... See more keywords
Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT)☆
Sign Up to like & getrecommendations! Published in 2017 at "Advanced Drug Delivery Reviews"
DOI: 10.1016/j.addr.2016.11.005
Abstract: Abstract While conventional treatment relies on protracted courses of therapy using relatively small dose‐per‐fraction sizes of 1.8–2 Gy, there is substantial evidence gathered over decades that this may not be the optimal approach for all… read more here.
Keywords: ablative body; body radiosurgery; therapy; stereotactic ablative ... See more keywords
A survey of compliance with stereotactic ablative body radiotherapy quality recommendations.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical imaging and radiation oncology"
DOI: 10.1111/1754-9485.13526
Abstract: INTRODUCTION Many publications have proposed quality standards for stereotactic ablative body radiotherapy (SABR). However, data on the level of compliance with these guidelines is lacking in the literature. This study aimed to understand how these… read more here.
Keywords: oncology; stereotactic ablative; quality; compliance ... See more keywords
Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2019 at "BMC Cancer"
DOI: 10.1186/s12885-019-5863-2
Abstract: BackgroundTo evaluate the outcome of patients treated with stereotactic ablative body radiotherapy (SABR) with curative intent for stage I non-small cell lung cancer (NSCLC) with regard to local, regional and distant tumor control, disease-free survival… read more here.
Keywords: ablative body; body radiotherapy; cancer; stereotactic ablative ... See more keywords